Published in Nature on March 15, 2007
Coherent multidimensional optical spectroscopy of excitons in molecular aggregates; quasiparticle versus supermolecule perspectives. Chem Rev (2009) 2.32
Engineering metallic nanostructures for plasmonics and nanophotonics. Rep Prog Phys (2012) 1.29
Atomically flat single-crystalline gold nanostructures for plasmonic nanocircuitry. Nat Commun (2010) 1.24
Ultrafast strong-field photoemission from plasmonic nanoparticles. Nano Lett (2013) 1.10
A polychromatic approach to far-field superlensing at visible wavelengths. Nat Commun (2012) 1.09
Spatiotemporal control of nanooptical excitations. Proc Natl Acad Sci U S A (2010) 0.99
Tailoring and imaging the plasmonic local density of states in crystalline nanoprisms. Nat Mater (2013) 0.93
Molding the flow of light on the nanoscale: from vortex nanogears to phase-operated plasmonic machinery. Nanoscale (2011) 0.91
Ultrafast strong-field photoelectron emission from biased metal surfaces: exact solution to time-dependent Schrödinger Equation. Sci Rep (2016) 0.86
Oriented assembly of polyhedral plasmonic nanoparticle clusters. Proc Natl Acad Sci U S A (2013) 0.84
Plasmonic antennas as design elements for coherent ultrafast nanophotonics. Proc Natl Acad Sci U S A (2013) 0.83
Imaging and controlling plasmonic interference fields at buried interfaces. Nat Commun (2016) 0.83
Photo-generated THz antennas. Sci Rep (2014) 0.82
Coherent control of plasmonic nanoantennas using optical eigenmodes. Sci Rep (2013) 0.81
Ultrafast control of third-order optical nonlinearities in fishnet metamaterials. Sci Rep (2016) 0.79
Coherent control of radiation patterns of nonlinear multiphoton processes in nanoparticles. Sci Rep (2015) 0.79
Adaptive on-chip control of nano-optical fields with optoplasmonic vortex nanogates. Opt Express (2011) 0.78
Nanoscale Imaging of Local Few-Femtosecond Near-Field Dynamics within a Single Plasmonic Nanoantenna. Nano Lett (2015) 0.76
Analytic Optimization of Near-Field Optical Chirality Enhancement. ACS Photonics (2017) 0.75
Dataset on coherent control of fields and induced currents in nonlinear multiphoton processes in a nanosphere. Sci Data (2015) 0.75
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet (2013) 8.02
Perioperative fluid therapy with tetrastarch and gelatin in cardiac surgery--a prospective sequential analysis*. Crit Care Med (2013) 5.88
Comparative efficacy, acceptability, and tolerability of augmentation agents in treatment-resistant depression: systematic review and network meta-analysis. J Clin Psychiatry (2015) 3.46
Graphene plasmonics: a platform for strong light-matter interactions. Nano Lett (2011) 3.44
Bipolar disorder. Lancet (2002) 3.26
Implementation of an evidence-based "standard operating procedure" and outcome in septic shock. Crit Care Med (2006) 3.18
Chronic and treatment resistant depression: diagnosis and stepwise therapy. Dtsch Arztebl Int (2014) 3.14
Genome-wide association study identifies genetic variation in neurocan as a susceptibility factor for bipolar disorder. Am J Hum Genet (2011) 2.71
A multicenter trial to compare blood culture with polymerase chain reaction in severe human sepsis. Intensive Care Med (2009) 2.60
Optical nano-imaging of gate-tunable graphene plasmons. Nature (2012) 2.55
Survival in critical illness is associated with early activation of mitochondrial biogenesis. Am J Respir Crit Care Med (2010) 2.48
Loss of cardiac microRNA-mediated regulation leads to dilated cardiomyopathy and heart failure. Circ Res (2009) 2.44
Renal effects of synthetic colloids and crystalloids in patients with severe sepsis: a prospective sequential comparison. Crit Care Med (2011) 2.30
The efficacy and safety of colloid resuscitation in the critically ill. Anesth Analg (2010) 2.23
Complete optical absorption in periodically patterned graphene. Phys Rev Lett (2012) 2.20
Antiplatelet drugs and outcome in mixed admissions to an intensive care unit. Crit Care Med (2010) 2.08
Dissecting the molecular relationship among various cardiogenic progenitor cells. Circ Res (2013) 2.06
New approaches to sepsis: molecular diagnostics and biomarkers. Clin Microbiol Rev (2012) 2.01
The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. Am J Psychiatry (2013) 1.97
Omega-3 fatty acids lower blood pressure by directly activating large-conductance Ca²⁺-dependent K⁺ channels. Proc Natl Acad Sci U S A (2013) 1.91
The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data. Brain Imaging Behav (2014) 1.90
Determination of spin injection and transport in a ferromagnet/organic semiconductor heterojunction by two-photon photoemission. Nat Mater (2008) 1.89
A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I). J Clin Psychiatry (2010) 1.85
Rapamycin reverses hypertrophic cardiomyopathy in a mouse model of LEOPARD syndrome-associated PTPN11 mutation. J Clin Invest (2011) 1.84
Prospective assessment of hepatic function and mechanisms of dysfunction in the critically ill. Shock (2009) 1.82
The late phase of sepsis is characterized by an increased microbiological burden and death rate. Crit Care (2011) 1.77
Reward anticipation and outcomes in adult males with attention-deficit/hyperactivity disorder. Neuroimage (2007) 1.71
Effects of fluid resuscitation with synthetic colloids or crystalloids alone on shock reversal, fluid balance, and patient outcomes in patients with severe sepsis: a prospective sequential analysis. Crit Care Med (2012) 1.71
Two-dimensional electronic spectroscopy of the B800-B820 light-harvesting complex. Proc Natl Acad Sci U S A (2006) 1.65
Exciton analysis in 2D electronic spectroscopy. J Phys Chem B (2005) 1.60
Peptidoglycan of Staphylococcus aureus causes inflammation and organ injury in the rat. Crit Care Med (2004) 1.57
Influence of heme-based solutions on stress protein expression and organ failure after hemorrhagic shock. Crit Care Med (2005) 1.53
Response and remission criteria in major depression--a validation of current practice. J Psychiatr Res (2010) 1.52
Plasma platelet-activating factor acetylhydrolase activity in critically ill patients. Crit Care Med (2005) 1.50
Modelling the optical response of gold nanoparticles. Chem Soc Rev (2008) 1.49
Nanoscale control of optical heating in complex plasmonic systems. ACS Nano (2010) 1.44
Halofuginone induces matrix metalloproteinases in rat hepatic stellate cells via activation of p38 and NFkappaB. J Biol Chem (2006) 1.40
Evolution of light-induced vapor generation at a liquid-immersed metallic nanoparticle. Nano Lett (2013) 1.34
Strategies for brain shift evaluation. Med Image Anal (2004) 1.32
Collapse of long-range charge order tracked by time-resolved photoemission at high momenta. Nature (2011) 1.30
Hepatic excretory function in sepsis: implications from biophotonic analysis of transcellular xenobiotic transport in a rodent model. Crit Care (2013) 1.29
Anisotropic metamaterials for full control of acoustic waves. Phys Rev Lett (2012) 1.28
Gated tunability and hybridization of localized plasmons in nanostructured graphene. ACS Nano (2013) 1.27
Liver dysfunction and phosphatidylinositol-3-kinase signalling in early sepsis: experimental studies in rodent models of peritonitis. PLoS Med (2012) 1.27
Anti-platelet drugs and outcome in severe infection: clinical impact and underlying mechanisms. Platelets (2009) 1.26
Zeptomol detection through controlled ultrasensitive surface-enhanced Raman scattering. J Am Chem Soc (2009) 1.26
Algorithms and collaborative-care systems for depression: are they effective and why? A systematic review. Biol Psychiatry (2006) 1.25
Probing bright and dark surface-plasmon modes in individual and coupled noble metal nanoparticles using an electron beam. Nano Lett (2009) 1.20
Acceleration and augmentation of antidepressants with lithium for depressive disorders: two meta-analyses of randomized, placebo-controlled trials. J Clin Psychiatry (2007) 1.19
The plasmon Talbot effect. Opt Express (2007) 1.17
Hyporeactivity of ventral striatum towards incentive stimuli in unmedicated depressed patients normalizes after treatment with escitalopram. J Psychopharmacol (2011) 1.17
Characteristics of clinical sepsis reflected in a reliable and reproducible rodent sepsis model. J Surg Res (2011) 1.17
Coherent two-dimensional nanoscopy. Science (2011) 1.15
Mapping the plasmon resonances of metallic nanoantennas. Nano Lett (2008) 1.14
Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression. J Affect Disord (2008) 1.13
Wnt signaling exerts an antiproliferative effect on adult cardiac progenitor cells through IGFBP3. Circ Res (2011) 1.13
A novel role for tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in the development of cardiac dysfunction and failure. Circulation (2009) 1.12
Evaluation of a polymerase chain reaction assay for pathogen detection in septic patients under routine condition: an observational study. PLoS One (2012) 1.12
Is dose escalation of antidepressants a rational strategy after a medium-dose treatment has failed? A systematic review. Eur Arch Psychiatry Clin Neurosci (2005) 1.11
Ventral striatal prediction error signaling is associated with dopamine synthesis capacity and fluid intelligence. Hum Brain Mapp (2012) 1.11
Femtosecond quantum control of molecular dynamics in the condensed phase. Phys Chem Chem Phys (2007) 1.11
Diagnostic guidelines for bipolar disorder: a summary of the International Society for Bipolar Disorders Diagnostic Guidelines Task Force Report. Bipolar Disord (2008) 1.11
Glucocorticoid receptor dimerization is required for survival in septic shock via suppression of interleukin-1 in macrophages. FASEB J (2011) 1.10
Altered representation of expected value in the orbitofrontal cortex in mania. Hum Brain Mapp (2010) 1.10
Low and "supranormal" central venous oxygen saturation and markers of tissue hypoxia in cardiac surgery patients: a prospective observational study. Intensive Care Med (2010) 1.10
Prevalence and treatment outcome in anxious versus nonanxious depression: results from the German Algorithm Project. J Clin Psychiatry (2010) 1.07
Preoperative serum pattern analysis to predict the outcome of tonsillectomy in adults with chronic tonsillitis. Eur Arch Otorhinolaryngol (2014) 1.07
Anemia and blood transfusion in a surgical intensive care unit. Crit Care (2010) 1.06
Inhibition of notch1-dependent cardiomyogenesis leads to a dilated myopathy in the neonatal heart. Circ Res (2010) 1.06
Efficacy and mechanisms of action of lithium augmentation in refractory major depression. Curr Pharm Des (2006) 1.04
Quantum finite-size effects in graphene plasmons. ACS Nano (2012) 1.04
Three-dimensional plasmonic chiral tetramers assembled by DNA origami. Nano Lett (2013) 1.04
Nanoparticles targeting the infarcted heart. Nano Lett (2011) 1.03
Cyber-support: an analysis of online self-help forums (online self-help forums in bipolar disorder). Nord J Psychiatry (2012) 1.03
Unique features of different members of the human guanylate-binding protein family. J Interferon Cytokine Res (2007) 1.02
Inhibitors of NADPH oxidase reduce the organ injury in hemorrhagic shock. Shock (2005) 1.02
DNA stool test for colorectal cancer: hypermethylation of the secreted frizzled-related protein-1 gene. Dis Colon Rectum (2007) 1.02
Hypothyroidism and mood disorders: integrating novel insights from brain imaging techniques. Thyroid Res (2011) 1.02
Neuronal injury regulates fractalkine: relevance for HIV-1 associated dementia. J Neuroimmunol (2003) 1.01
How grooves reflect and confine surfaceplasmon polaritons. Opt Express (2009) 1.01
Analytic coherent control of plasmon propagation in nanostructures. Opt Express (2009) 1.01
Intracellular trafficking of guanylate-binding proteins is regulated by heterodimerization in a hierarchical manner. PLoS One (2010) 1.01
Human guanylate binding protein-1 (hGBP-1) characterizes and establishes a non-angiogenic endothelial cell activation phenotype in inflammatory diseases. Adv Enzyme Regul (2005) 1.01
Utility of the WHO-Five Well-being Index as a screening tool for depression in Parkinson's disease. Mov Disord (2010) 1.00
Mood episodes and mood disorders: patterns of incidence and conversion in the first three decades of life. Bipolar Disord (2009) 1.00
Impact of plasma histones in human sepsis and their contribution to cellular injury and inflammation. Crit Care (2014) 1.00
Substantial performance discrepancies among commercially available kits for reverse transcription quantitative polymerase chain reaction: a systematic comparative investigator-driven approach. Anal Biochem (2010) 1.00
Spatiotemporal control of nanooptical excitations. Proc Natl Acad Sci U S A (2010) 0.99
A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder. J Psychiatr Res (2007) 0.98
Truncated human cytidylate-phosphate-deoxyguanylate-binding protein for improved nucleic acid amplification technique-based detection of bacterial species in human samples. J Clin Microbiol (2009) 0.98
The International Consortium on Lithium Genetics (ConLiGen): an initiative by the NIMH and IGSLI to study the genetic basis of response to lithium treatment. Neuropsychobiology (2010) 0.98
Quality of life outcomes among patients with depression after 6 months of starting treatment: results from FINDER. J Affect Disord (2008) 0.98